Sitemap > Breaking Research > Immunology & Inflammatory Diseases
Displaying 401 - 450 of 5698 results
- Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
- Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment.
- Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
- Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
- Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.
- Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
- Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.
- Lactams as prostanoid receptor ligands. Part 4: 2-Piperidones as selective EP4 receptor agonists.
- Identification of chemokine receptor CCR4 antagonist.
- Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2).
- Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
- Effective antitumour mono- and combination therapy by gene delivery of angiostatin-like molecule and interleukin-12 in a murine hepatoma model.
- Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study.
- Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis.
- Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}.
- Characterization of a mouse second leukotriene B4 receptor, mBLT2: BLT2-dependent ERK activation and cell migration of primary mouse keratinocytes.
- Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients.
- Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
- Origin and anti-tumor effects of anti-dsDNA autoantibodies in cancer patients and tumor-bearing mice.
- Adalimumab in clinical practice. Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure.
- A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
- Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1.
- Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
- A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential.
- The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation.
- A calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial.
- Daclizumab is associated with decreased rejection and improved patient survival in renal transplant recipients.
- The evaluation of 2,8-disubstituted benzoxazinone derivatives as anti-inflammatory and anti-platelet aggregation agents.
- Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy.
- IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.
- Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.
- Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions.
- A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
- Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis.
- The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle.
- Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
- Abrogation of bronchial eosinophilic inflammation and attenuated eotaxin content in protease-activated receptor 2-deficient mice.
- Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.
- Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
- Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
- An international cohort study of cancer in systemic lupus erythematosus.
- Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
- Panorama Ab Microarray Cell Signaling kit: a unique tool for protein expression analysis.
- Design, construction, and characterization of a large synthetic human antibody phage display library.
- Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction.
- Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
- Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma.
- Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.
- Expression of P2X4 receptor by lesional activated microglia during formalin-induced inflammatory pain.
- Thrombin peptide (TP508) promotes fracture repair by up-regulating inflammatory mediators, early growth factors, and increasing angiogenesis.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | 100 | 101 | 102 | 103 | 104 | 105 | 106 | 107 | 108 | 109 | 110 | 111 | 112 | 113 | 114 Next >